High risk prostate cancer and mHSPC | With Axel Merseburger

Written By Declan Murphy

Axel Merseburger (Chief and Professor of Urology, Lubeck, Germany) was in Australia recently and popped into the GU Cast studio for a chat. Axel was at the USANZ ASM recently and also on a speaker tour supported by Janssen Pharmaceuticals, so we put together this Themed Podcast to pick his brains on high-risk prostate cancer and mHSPC in 2024.

This Themed Podcast is supported by Janssen Pharmaceuticals, Gold Partners of GU Cast. Also available as an audio podcast in all the usual places

 

Also available as an audio podcast in all the usual places

Declan Murphy
Previous

Happy days for metastatic bladder cancer | Enrique Grande and Andrew Weickhardt
Next

#USANZ24 Conference Highlights